- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Synthetic glucagon analogue modified to contain 7 amino acid
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Synthetic glucagon analogue modified to contain 7 amino acid substitutions
| EU orphan designation number: | EU/3/17/1887
|
| Active ingredient: | Synthetic glucagon analogue modified to contain 7 amino acid substitutions |
| Indication: | Treatment of congenital hyperinsulinism |
| Sponsor: | Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, Denmark |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 23/06/2017 | Orphan designation | EMA/OD/002/17 | (2017)4373 of 20/06/2017 |
CONTACT
EU links
Directorate General Health & Consumers